Abstract:and analgesic procedures. Myoclonus after regional anesthesia has rarely been reported, but there have been a few reports of myoclonus after a peripheral nerve block. We report a very rare case of myoclonus after a supraclavicular brachial plexus block in a healthy patient with a brief review of literature. A 22-year-old woman (height: 160 cm, body weight: 46 kg, American Society of Anesthesiologists physical status I) was scheduled for a capsular release operation. There was nothing specific in her past medical history. She had previously undergone an uncomplicated left hand procedure under general anesthesia with no anesthesia-related adverse events. Preoperative evaluations were also normal. A supraclavicular brachial plexus block was planned for the anesthesia. Electrocardiography, noninvasive blood pressure, and pulse oximetry were monitored. Before induction of anesthesia, midazolam 2 mg and fentanyl 50 μg were intravenously injected for sedation and pain relief. At the beginning of nerve block, her blood pressure and heart rate were 120/75 mmHg and 65 beats/min. A supraclavicular brachial plexus block was performed under ultrasonographic guidance with a 5 cm standard bevel needle (Profi needle, Shinchang medical Co., Seoul, Korea). We injected 1.5% mepivacaine 40 ml after confirming no aspiration of blood. She did not complain of any severe paresthesia or injection pain during the procedure. Fifteen minutes after procedure, we confirmed successful sensory and motor block of brachial plexus and 5 L/min of oxygen was supplied via facial mask during the operation. An additional 1 mg of midazolam was given intravenously for sedation. The patient was stable during the surgery and the duration of surgical procedure was about 40 minutes. After the surgical procedure, the patient was transferred to a recovery room. One hour after the injection of the local anesthetic, she showed a shivering motion without any chilling sensation. The body temperature was 36.7°C. Meperidine 25 mg was intravenously injected to relieve shivering and 5 L/min of oxygen was supplied via facial mask. However, her shivering continued for about 15 minutes and the patient began to show mild agitation. Thirty minutes after meperidine injection, she showed involuntary movement of left arm, while the other body parts were under control (Video 1). The patient was unable to suppress the movement intentionally but remained conscious and communicated appropriately. She did not complain of pain or any other discomfort and there were no other neurologic symptoms. The driving force for the abnormal movement was from the surrounding muscles of the shoulder with some contribution from the muscles of the elbow joint. We consulted to neurology and the patient was treated with an intravenous injection of midazolam 5 mg but it was not effective. The movement continued while patient was sedated with midazolam. The neurologist examined the patient and about 20 minutes after midazolam injection, lorazepam 4 mg was administered intravenously but it was also not effective. The abnormal movement did Letter to the Editor

Cross-validation of short forms of the WISC-R in two British samples.

Activation of Hypersensitive Cell Death by Pathogen-Induced Receptor-Like Protein Kinases from Arabidopsis

Mapping of VSG genes on large expression-site chromosomes of Trypanosoma brucei separated by pulsed-field gradient electrophoresis.

Arterial stiffness and vascular complications in patients with type 1 diabetes: The Finnish Diabetic Nephropathy (FinnDiane) Study

Language production in Parkinson's disease: Acoustic and linguistic considerations

Myoclonus of ipsilateral upper extremity after ultrasound-guided supraclavicular brachial plexus block with mepivacaine

Reducing the weight of cancer: mechanistic targets for breaking the obesity-carcinogenesis link.

Evolutionary Analysis of CBL-interacting Protein Kinase Gene Family in Plants

The Mechanism of CBL-CIPK Signal Transduction under Stresses in Plants

Distal–proximal skin temperature gradient prior to sleep onset in infants for clinical use

Turkish pharmacists’ counseling practices and attitudes regarding emergency contraceptive pills

Protein Phosphorylation Dynamics Under Carbon/Nitrogen-Nutrient Stress and Identification of a Cell Death-Related Receptor-Like Kinase in Arabidopsis

Functional Characterization of BdCIPK31 in Plant Response to Potassium Deficiency Stress

A Novel Role For Arabidopsis Cbl1 In Affecting Plant Responses To Glucose And Gibberellin During Germination And Seedling Development

Two Calcium-Dependent Protein Kinases, CPK4 and CPK11, Regulate Abscisic Acid Signal Transduction in Arabidopsis.

A CBL-interacting Protein Kinase TaCIPK27 Confers Drought Tolerance and Exogenous ABA Sensitivity in Transgenic Arabidopsis.

The calcineurin β-like interacting protein kinase CIPK25 regulates potassium homeostasis under low oxygen in Arabidopsis

AtCIPK20 regulates microtubule stability to mediate stomatal closure under drought stress in Arabidopsis

ABI1 regulates carbon/nitrogen-nutrient signal transduction independent of ABA biosynthesis and canonical ABA signalling pathways in Arabidopsis

The kinase CIPK14 functions as a negative regulator of plant immune responses to Pseudomonas syringae in Arabidopsis

The CBL-CIPK network mediates different signaling pathways in plants